New Studies

New studies reveal significant medical progression for mesothelioma patients of all stages. Know which treatments are working best and which aren’t.

New Studies | Prognosis | Research | Surgery | Treatments

Length of Time Between Surgeries a Marker for Mesothelioma Survival
ByAlex Strauss June 14, 2017

Peritoneal mesothelioma patients who survive more than two years after surgery are the ones most likely to benefit from a…

Read More Length of Time Between Surgeries a Marker for Mesothelioma Survival
Alternatives | Asia | International | Multi-Modality Therapy | New Drugs | New Studies | Research | Treatments

Cholesterol Drug May Protect Mesothelioma Patients from Radiation
ByAlex Strauss June 3, 2017

A new study suggests that the cholesterol-lowering drug pravastatin could one-day be used to help protect mesothelioma patients from the…

Read More Cholesterol Drug May Protect Mesothelioma Patients from Radiation
Chemotherapy | Europe | International | Multi-Modality Therapy | New Studies | Research | Treatments

Standardization Needed for Peritoneal Mesothelioma Treatment
ByAlex Strauss May 27, 2017

Mesothelioma researchers in Belgium and the US have some good news and some bad news about peritoneal mesothelioma treatment. The…

Read More Standardization Needed for Peritoneal Mesothelioma Treatment
Immune Systems | Immunotherapy | Multi-Modality Therapy | New Studies | Radiation Therapy | Research

Immunotherapy and Radiation: A Powerful Mesothelioma Combo
ByAlex Strauss May 23, 2017March 1, 2018

New research suggests that, in the battle against malignant pleural mesothelioma, a treatment combining immunotherapy drugs with radiotherapy may be a powerful…

Read More Immunotherapy and Radiation: A Powerful Mesothelioma Combo
Asia | Biomarkers | Diagnosis | International | New Studies | Prognosis | Research

Predicting Mesothelioma Outcomes with Soluble Mesothelin
ByAlex Strauss May 19, 2017

New research suggests that a protein often used to help diagnose and track malignant mesothelioma may also be a valuable…

Read More Predicting Mesothelioma Outcomes with Soluble Mesothelin
Europe | International | Multi-Modality Therapy | New Studies | Radiation Therapy | Research | Treatments

IMRT Beats Conformal Radiotherapy for Pleural Mesothelioma
ByAlex Strauss May 9, 2017

The targeted radiotherapy technique known as intensity-modulated radiotherapy (IMRT) may offer a safer way to treat pleural mesothelioma tumors with…

Read More IMRT Beats Conformal Radiotherapy for Pleural Mesothelioma
Europe | International | Multi-Modality Therapy | New Studies | Research | Surgery | Treatments

New Report May Fuel Debate Over Mesothelioma Surgery
ByAlex Strauss May 3, 2017May 11, 2017

A new Swiss report on the two major types of mesothelioma surgery appears to raise as many questions as it…

Read More New Report May Fuel Debate Over Mesothelioma Surgery
Chemotherapy | Multi-Modality Therapy | New Drugs | New Studies | Research | Treatments

VEGF-Inhibitor Looks Promising for Malignant Mesothelioma
ByAlex Strauss May 1, 2017

There is more encouraging news about the monoclonal antibody bevacizumab (Avastin) and its potential to boost the effectiveness of chemotherapy…

Read More VEGF-Inhibitor Looks Promising for Malignant Mesothelioma
Asia | Chemotherapy | International | Multi-Modality Therapy | New Studies | Research | Surgery | Treatments

Additional Chemotherapy Extends Survival in Relapsed Mesothelioma Patients
ByAlex Strauss April 27, 2017March 23, 2019

Mesothelioma patients who experience a recurrence of their asbestos cancer after radical surgery may live longer if they undergo additional…

Read More Additional Chemotherapy Extends Survival in Relapsed Mesothelioma Patients
Europe | International | New Studies | Prognosis | Research | Surgery | Treatments

Lung-Sparing Surgery and Mesothelioma Survival
ByAlex Strauss April 19, 2017

When it comes to the mesothelioma surgery known as pleurectomy/decortication (P/D), not all techniques are created equal. A new report…

Read More Lung-Sparing Surgery and Mesothelioma Survival

1 (888) 378-1331

New Studies

Length of Time Between Surgeries a Marker for Mesothelioma Survival

Cholesterol Drug May Protect Mesothelioma Patients from Radiation

Standardization Needed for Peritoneal Mesothelioma Treatment

Immunotherapy and Radiation: A Powerful Mesothelioma Combo

Predicting Mesothelioma Outcomes with Soluble Mesothelin

IMRT Beats Conformal Radiotherapy for Pleural Mesothelioma

New Report May Fuel Debate Over Mesothelioma Surgery

VEGF-Inhibitor Looks Promising for Malignant Mesothelioma

Additional Chemotherapy Extends Survival in Relapsed Mesothelioma Patients

Lung-Sparing Surgery and Mesothelioma Survival

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES